6-(3,4-Dichlorophenyl)-1-[(Methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: A New Potent and Selective Triple Reuptake Inhibitor

Author:

Micheli Fabrizio1,Cavanni Paolo1,Andreotti Daniele1,Arban Roberto1,Benedetti Roberto1,Bertani Barbara1,Bettati Michela1,Bettelini Letizia1,Bonanomi Giorgio1,Braggio Simone1,Carletti Renzo1,Checchia Anna1,Corsi Mauro1,Fazzolari Elettra1,Fontana Stefano1,Marchioro Carla2,Merlo-Pich Emilio1,Negri Michele1,Oliosi Beatrice2,Ratti Emiliangelo1,Read Kevin D.3,Roscic Maja4,Sartori Ilaria1,Spada Simone1,Tedesco Giovanna2,Tarsi Luca1,Terreni Silvia1,Visentini Filippo2,Zocchi Alessandro1,Zonzini Laura1,Di Fabio Romano1

Affiliation:

1. Neurosciences Centre of Excellence for Drug Discovery

2. Molecular Discovery Research

3. Biological Chemistry and Drug Discovery, College of Life Sciences, Sir James Black Centre, University of Dundee, Dundee, DD1 5EH, Scotland, U.K.

4. GlaxoSmithKline Research Centre Zagreb Ltd., Prilaz Baruna Filipovica 29, 10000 Zagreb, Croatia

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3